These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

737 related articles for article (PubMed ID: 28491867)

  • 1. Metabolic Reprogramming in Glioma.
    Strickland M; Stoll EA
    Front Cell Dev Biol; 2017; 5():43. PubMed ID: 28491867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Caffeic Acid Targets AMPK Signaling and Regulates Tricarboxylic Acid Cycle Anaplerosis while Metformin Downregulates HIF-1α-Induced Glycolytic Enzymes in Human Cervical Squamous Cell Carcinoma Lines.
    Tyszka-Czochara M; Bukowska-Strakova K; Kocemba-Pilarczyk KA; Majka M
    Nutrients; 2018 Jun; 10(7):. PubMed ID: 29958416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic dysregulation of tricarboxylic acid cycle and oxidative phosphorylation in glioblastoma.
    Trejo-Solís C; Serrano-García N; Castillo-Rodríguez RA; Robledo-Cadena DX; Jimenez-Farfan D; Marín-Hernández Á; Silva-Adaya D; Rodríguez-Pérez CE; Gallardo-Pérez JC
    Rev Neurosci; 2024 Oct; 35(7):813-838. PubMed ID: 38841811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Glycolytic and Glutamine Metabolism Reprogramming on the Proliferation, Invasion, and Apoptosis Resistance through Modulation of Signaling Pathways in Glioblastoma.
    Trejo-Solis C; Silva-Adaya D; Serrano-García N; Magaña-Maldonado R; Jimenez-Farfan D; Ferreira-Guerrero E; Cruz-Salgado A; Castillo-Rodriguez RA
    Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic Roles of HIF1, c-Myc, and p53 in Glioma Cells.
    Trejo-Solís C; Castillo-Rodríguez RA; Serrano-García N; Silva-Adaya D; Vargas-Cruz S; Chávez-Cortéz EG; Gallardo-Pérez JC; Zavala-Vega S; Cruz-Salgado A; Magaña-Maldonado R
    Metabolites; 2024 Apr; 14(5):. PubMed ID: 38786726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Warburg effect: essential part of metabolic reprogramming and central contributor to cancer progression.
    Vaupel P; Schmidberger H; Mayer A
    Int J Radiat Biol; 2019 Jul; 95(7):912-919. PubMed ID: 30822194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor microenvironment and metabolic synergy in breast cancers: critical importance of mitochondrial fuels and function.
    Martinez-Outschoorn U; Sotgia F; Lisanti MP
    Semin Oncol; 2014 Apr; 41(2):195-216. PubMed ID: 24787293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endocytosis-mediated mitochondrial transplantation: Transferring normal human astrocytic mitochondria into glioma cells rescues aerobic respiration and enhances radiosensitivity.
    Sun C; Liu X; Wang B; Wang Z; Liu Y; Di C; Si J; Li H; Wu Q; Xu D; Li J; Li G; Wang Y; Wang F; Zhang H
    Theranostics; 2019; 9(12):3595-3607. PubMed ID: 31281500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolism and brain cancer.
    Marie SK; Shinjo SM
    Clinics (Sao Paulo); 2011; 66 Suppl 1(Suppl 1):33-43. PubMed ID: 21779721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic reprogramming in cancer cells: glycolysis, glutaminolysis, and Bcl-2 proteins as novel therapeutic targets for cancer.
    Li C; Zhang G; Zhao L; Ma Z; Chen H
    World J Surg Oncol; 2016 Jan; 14(1):15. PubMed ID: 26791262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial biogenesis: pharmacological approaches.
    Valero T
    Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in the role of AMP-activated protein kinase in metabolic reprogramming of metastatic cancer cells: targeting cellular bioenergetics and biosynthetic pathways for anti-tumor treatment.
    Tyszka-Czochara M; Konieczny P; Majka M
    J Physiol Pharmacol; 2018 Jun; 69(3):. PubMed ID: 30279304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic phenotype of bladder cancer.
    Massari F; Ciccarese C; Santoni M; Iacovelli R; Mazzucchelli R; Piva F; Scarpelli M; Berardi R; Tortora G; Lopez-Beltran A; Cheng L; Montironi R
    Cancer Treat Rev; 2016 Apr; 45():46-57. PubMed ID: 26975021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Metabolic Therapy for Malignant Glioma Requires a Clinical Measure.
    Corbin Z; Spielman D; Recht L
    Curr Oncol Rep; 2017 Nov; 19(12):84. PubMed ID: 29098465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formyl-Peptide Receptor 2 Signaling Redirects Glucose and Glutamine into Anabolic Pathways in Metabolic Reprogramming of Lung Cancer Cells.
    Pecchillo Cimmino T; Pagano E; Stornaiuolo M; Esposito G; Ammendola R; Cattaneo F
    Antioxidants (Basel); 2022 Aug; 11(9):. PubMed ID: 36139766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic reprogramming in glioblastoma: the influence of cancer metabolism on epigenetics and unanswered questions.
    Agnihotri S; Zadeh G
    Neuro Oncol; 2016 Feb; 18(2):160-72. PubMed ID: 26180081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A key role for transketolase-like 1 in tumor metabolic reprogramming.
    Diaz-Moralli S; Aguilar E; Marin S; Coy JF; Dewerchin M; Antoniewicz MR; Meca-Cortés O; Notebaert L; Ghesquière B; Eelen G; Thomson TM; Carmeliet P; Cascante M
    Oncotarget; 2016 Aug; 7(32):51875-51897. PubMed ID: 27391434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of Metabolic Reprogramming in Cancer Cells Supporting Enhanced Growth and Proliferation.
    Schiliro C; Firestein BL
    Cells; 2021 Apr; 10(5):. PubMed ID: 33946927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted cancer therapeutics: biosynthetic and energetic pathways characterized by metabolomics and the interplay with key cancer regulatory factors.
    Dang NH; Singla AK; Mackay EM; Jirik FR; Weljie AM
    Curr Pharm Des; 2014; 20(15):2637-47. PubMed ID: 23859615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histochemical evaluation of energy metabolism in rat glioma.
    Ikezaki K; Black KL; Conklin SG; Becker DP
    Neurol Res; 1992 Sep; 14(4):289-93. PubMed ID: 1360622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.